Antagonists of the Vasopressin V1 Receptor and of the &bgr;<sub>1</sub>-Adrenoceptor Inhibit Cytotoxic Brain Edema in Stroke by Effects on Astrocytes-but the Mechanisms Differ

By  

Current Neuropharmacology, Vol. 12, Iss. 4, 2014-07 ,pp. : 308-323

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists

By Hagiwara Yohsuke  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 8, 2013-11 ,pp. : 951-964

Informa Healthcare

Access to resources Recommend Favorite

Non-Peptide Vasopressin V1b Receptor Antagonists as Potential Drugs for the Treatment of Stress-Related Disorders

By  

Current Pharmaceutical Design, Vol. 11, Iss. 12, 2005-05 ,pp. : 1549-1559

Bentham Science Publishers

Access to resources Recommend Favorite

Evidence that atypical vasopressin V 2 receptor in inner medulla of kidney is V 1B receptor

By Saito M.   Tahara A.   Sugimoto T.   Abe K.   Furuichi K.  

European Journal of Pharmacology, Vol. 401, Iss. 3, 2000-08 ,pp. : 289-296

Elsevier

Access to resources Recommend Favorite

In vivo and in vitro characterisation of a nonpeptide vasopressin V 1A and V 2 receptor antagonist (YM087) in the rat

By Risvanis J.   Naitoh M.   Johnston C.I.   Burrell L.M.  

European Journal of Pharmacology, Vol. 381, Iss. 1, 1999-09 ,pp. : 23-30

Elsevier

Access to resources Recommend Favorite